Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.
Saved in:
| Title: | Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice. |
|---|---|
| Authors: | Thomas KR; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA., Allenspach EJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.; Brotman-Baty Institute for Precision Medicine, Seattle, WA, USA., Camp ND; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA., Wray-Dutra MN; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA., Khim S; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA., Zielinska-Kwiatkowska A; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA., Timms AE; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA., Loftus JP; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Liggitt HD; Department of Comparative Medicine, University of Washington School of Medicine, Seattle, WA, USA., Georgopoulos K; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA., Tasian SK; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., James RG; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA. rickerj@uw.edu.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. rickerj@uw.edu.; Brotman-Baty Institute for Precision Medicine, Seattle, WA, USA. rickerj@uw.edu.; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA. rickerj@uw.edu., Rawlings DJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA. drawling@uw.edu.; Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA. drawling@uw.edu.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. drawling@uw.edu. |
| Source: | Leukemia [Leukemia] 2022 Jan; Vol. 36 (1), pp. 42-57. Date of Electronic Publication: 2021 Jun 30. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
